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Abstract
Background: The effects of Plasmodium falciparum on B-cell homeostasis have not been well
characterized. This study investigated whether an episode of acute malaria in young children results
in changes in the peripheral B cell phenotype.
Methods: Using flow-cytofluorimetric analysis, the B cell phenotypes found in the peripheral blood
of children aged 2–5 years were characterized during an episode of acute uncomplicated clinical
malaria and four weeks post-recovery and in healthy age-matched controls.
Results: There was a significant decrease in CD19+ B lymphocytes during acute malaria.
Characterization of the CD19+ B cell subsets in the peripheral blood based on expression of IgD
and CD38 revealed a significant decrease in the numbers of naive 1 CD38-IgD+ B cells while there
was an increase in CD38+IgD- memory 3 B cells during acute malaria. Further analysis of the
peripheral B cell phenotype also identified an expansion of transitional CD10+CD19+ B cells in
children following an episode of acute malaria with up to 25% of total CD19+ B cell pool residing
in this subset.
Conclusion: Children experiencing an episode of acute uncomplicated clinical malaria
experienced profound disturbances in B cell homeostasis.
Background
There are over 500 million episodes of clinical Plasmodium
falciparum malaria annually [1]. The primary burden of
infections with P. falciparum occurs mainly in children
under five years of age living in the tropical and sub-trop-
ical areas of the world, where malaria transmission is
holoendemic [2,3]. Malaria induces many pathophysio-
logical changes including alterations in both T and B cell
immunity [4]. In addition, in regions where malaria trans-
mission is holoendemic, immunity is not acquired until
after several years of exposure and can be lost rapidly fol-
lowing migration out of a malaria endemic region sug-
Published: 18 November 2008
Malaria Journal 2008, 7:238 doi:10.1186/1475-2875-7-238
Received: 21 July 2008
Accepted: 18 November 2008
This article is available from: http://www.malariajournal.com/content/7/1/238
© 2008 Asito et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Malaria Journal 2008, 7:238 http://www.malariajournal.com/content/7/1/238
Page 2 of 8
(page number not for citation purposes)
gesting poor generation of protective immune memory
[5-7]. The mechanism of immune suppression induced by
P. falciparum remains an important question to solve in
order to achieve protective immunity by means of vacci-
nation.
A number of observations clearly indicate that B cells are
affected by P. falciparum infection. Hypergammaglobuli-
naemia has been a well-described feature of Plasmodium
infections [8] and persons living in malaria holoendemic
regions have elevated total antibody levels [9]. Dorfman et
al [10] reported a diminished frequency of P. falciparum-
specific memory B cells as indicated by loss of P. falci-
parum antibodies, and Kassa et al [11] reported a decline
in total numbers of CD19+ B cells. Polyclonal B cell acti-
vation induced by P. falciparum [9] most likely occurs
through antigenic activation by the cysteine-rich interdo-
main region α (CIDR1α) of P. falciparum erythrocyte
membrane protein 1(PfEMP1) and merozoite antigens
[12].
In addition to disturbances in generation and mainte-
nance of B cell immunity following P. falciparum infec-
tion, chronic antigenic activation of B cells within the
context of repeated P. falciparum infections may lead to
cytogenic abnormalities or aberrations in B cell develop-
ment and trafficking. This may be one possible explana-
tion for the increased risk for Burkitt's lymphoma in
children living in malaria endemic settings [13].
Although there is some data on the types and frequencies
of mature B cells that populate the peripheral blood in
healthy children and HIV infected children [14], few stud-
ies have examined these changes in B cell subsets as they
occur in peripheral blood of children in malaria endemic
regions, who bear the burden of malaria related mortality
and morbidity. Kassa et al [11] found a decrease in total
CD19+ B cells following acute P. falciparum and P. vivax
infections, but no further phenotyping of B cell subsets
was done. Recent development in B cell biology allow dis-
tinctions of peripheral B cells into distinct subsets i.e.
naive (CD19+IgD+) and memory (CD19+IgD-) subsets
based on IgD staining [15]. Further delineation of periph-
eral B cells was reported by Bonhorst et al [15]. They used
relative levels on IgD and CD38 expression to identify
four different B cell sub-populations in peripheral blood.
Other markers to delineate peripheral B cell subsets
include CD10, which was initially thought to be a marker
for germinal center B cells and Burkitt lymphoma cells
[16,17]. However, CD10 was recently shown to be
expressed on a subset of peripheral B cells known as
immature transitional B cells [18,19]. Infection with HIV
was shown to increase CD10+CD19+ immature transi-
tional B cells suggesting that the transitional B cells are
potential marker of inflammation. Whether P. falciparum
infection induces these cells is unknown.
To understand how P. falciparum infection modulates B
cell homeostasis, flow cytofluorimetric (FCF) analysis was
used to quantify the percentage of total B cells (CD19+)
and to discriminate B cell subsets in the peripheral blood
in children experiencing an acute clinical case of P. falci-
parum malaria and four weeks following recovery. In this
study, it was shown that following acute clinical P. falci-
parum malaria there were significant increases in CD10+ B
cells as well as a decline in CD19+IgD-CD38- population
of memory B cells.
Methods
Study area
This study was carried out at Chulaimbo Rural Training
Center during the months of June and July 2003. This
clinic serves a malaria holoendemic area [13] and is
located 25 km from Kisumu City in Nyanza Province,
Western Kenya. Falciparum malaria accounts for 98% of
malarial infections in this region.
Study participants
All the protocols used in this study were reviewed and
approved by the Kenya Medical Research Institute
(KEMRI) Ethical Review Committee and Institutional
Review Board of Human Studies at University Hospitals of
Cleveland, Case Western Reserve University, USA. After
informed consent was obtained from the parents or
guardians, twenty-five children aged 2–6 years presenting
with acute clinical malaria (based on clinical signs deter-
mined by a clinical officer) were enrolled in the study. All
malaria cases were treated according to the Kenyan
national malaria treatment policy set in 1998 which using
sulphadoxine-pyrimethamine (SP) as the first-line anti-
malaria treatment. Inclusion criteria for children in the
study included parental/guardians consent for blood sam-
ples to be drawn twice within four weeks, age two to six
years, and admission with a diagnosis of acute malaria
morbidity as defined by an axillary temperature ≥37.5°C
and P. falciparum parasitaemia ≥5,000 parasites/μl. Chil-
dren were excluded from the study if they were severely
immunosuppressed, malnourished, or had other concur-
rent infections that may cause fever such as lower respira-
tory tract infection; had haemoglobin (Hb) less than 5 g/
dl; and parasitaemia with fever at the follow-up visit four
weeks after enrollment in this study or relocation from
study area. Follow-up was conducted four weeks post-
recovery. Fifteen children met the inclusion criteria and
were further analysed. Ten children were excluded from
the study at follow-up based on the exclusion criteria (e.g.
relocation from study area, parasitaemia with fever at the
follow-up, and Hb levels needing transfusion between
enrollment and follow-up). Eleven healthy-age matched
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children who were parasitaemic, but asymptomatic, and
from the same geographic area were included as controls.
The clinical and the demographic data of the study partic-
ipants are displayed in Table 1.
Blood collection
After measurements of haemoglobin levels using a porta-
ble B-haemoglobin photometer (Hemocue AB Angel-
holm, Sweden), thick and thin blood films were prepared
from finger prick samples and stained with 5% Giemsa to
determine Plasmodium species and level of parasitaemia.
Following microscopic confirmation of P. falciparum par-
asitaemia of sufficient density, 2–5 ml of blood whole
blood was collected in EDTA vacutainer by venipuncture.
Lymphocyte isolation and cryopreservation
Blood was anticoagulated in EDTA and peripheral blood
mononuclear cells (PBMC) were separated from whole
blood by Ficoll-Hypaque density gradient centrifugation
within two hours of venipuncture. Cell viability was deter-
mined using the trypan blue dye exclusion assay. Cells
were resuspended in 1 ml of freezing media (50% foetal
bovine serum, 40% RPMI, and 10% DMSO) and stored at
-80°C for later batch analysis by flow cytometry.
Immunophenotyping of peripheral blood lymphocytes
Cryropreserved peripheral blood mononuclear cells were
quickly thawed in a water bath at 37°C, washed in cold
PBS with 3% BSA and 10 mM HEPES. PBMC were enu-
merated using a heamocytometer, and viability routinely
assessed to be above 90%. A total of 3 × 105 cells/100 μl
flow buffer (PBS, 3% BSA) were stained on ice with the
following antibodies to lymphocyte surface receptors:
CD3-FITC, CD8-FITC, IgD-FITC, CD38-FITC, CD19-PE,
CD4-PE, CD38-PE, CD-10PE, CD23-PE, CD45-APC,
CD3-APC, and CD19-APC (BD Pharmingen, CA, San
Diego, USA). Isotype controls were IgG2a, K -FITC
(mouse), IgG1, K -PE (mouse) and IgG1, K -FITC (mouse)
(BD Pharmingen). After staining, cells were fixed with 1%
paraformaldehyde for 15 minutes, and then resuspended
in 300 μl flow buffer for analysis on a FACS Calibur flow
cytometer (Becton Dickinson Immunocytometry Systems,
San Jose, USA). Data was analysed using CellQuestPro
software (BD Immunocytometry Systems).
Immunoglobulin assays
Total immunoglobulin (IgG, IgM and IgA) was measured
using standard capture and detection sandwich enzyme
linked immunosorbent assay (ELISA) [20]. The plates
were read on an automated OpsysMR microplate reader at
410 nm (DYNEX Technologies, USA). Immunoglobulin
concentration were determined by extrapolation from the
standard curves.
Statistical analysis
Paired T-test was used to compare the differences in
means of the same individuals at different time points
(clinical patients, acute versus post-recovery). Independ-
ent-measures T-test was used to compare differences
between acute clinical patients, post-recovery and an age-
matched control group. Heterogeneity of variance
assumptions was tested by the Levene statistic. In all cases
P < 0.05 were considered statistically significant. SPSS v16
(SPSS, Inc., Chicago, IL) was used for statistical analysis.
Results
General characteristics of the study population
Twenty-five children presenting with acute clinical
malaria were enrolled in this study. However, during fol-
low-up conducted four weeks post recovery, only fifteen
children met enrollment criteria and were included in the
subsequent analysis. Clinical characteristics of the study
participants are shown in Table 1. The mean age of the
enrollees was 42.4 months, while controls were 42.8
months. Children presenting with acute uncomplicated
clinical malaria had a mean P. falciparum parasite density/
μl of 47,066 ± 32,105. Four weeks following treatment for
malaria, the parasite density had dropped in all cases with
a mean density of 3,464 parasites/μl. Some of the controls
were asymptomatic, but parasitaemic and had a mean
density of 1,820 parasites/μl. Children who had acute
clinical malaria had the highest temperature (mean of
37.8°C), whereas during recovery they had comparable
temperature to the control children (mean of 36.5°C).
The haemoglobin levels were 8.6 g/dL, 10.3 g/dL, and
10.7 g/dL for acute clinical malaria, post-recovery and
controls respectively.
Table 1: General clinical characteristics of the study subject
Study participant status Acute clinical malaria, n = 15 Post recovery, n = 15 Controls, n = 11
Temperature (°C) [range] 37.8* [37.5–39.9] 36.5 [34.9–37.3] 36.3 [35.4–36.8]
Hemoglobin levels (g/dl) [range] 8.6 [6.5–12.4] 10.3 [6.2–14.0] 10.67 [8.6–11.6]
Parasite density/μl [range] 47066 [11280–141960] 3464 [0–18280] 1820 [680–3000]
*Values are arithmetic mean of the variables assessed in the three clinical groups
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Changes in CD19+ B cells in children with acute clinical 
malaria
Since acute clinical malaria has been associated with per-
turbation of lymphocyte populations [11,21], the fre-
quency of T and B cells in peripheral blood of children
was first examined during acute clinical malaria and post-
recovery. These values were then compared with T and B
cell frequencies in healthy age-matched controls. Follow-
ing recovery from malaria, children had a significantly
higher percentage of CD19+ B cells relative to when they
had an episode of acute clinical malaria (P = 0.02) (Table
2). In contrast, no significant differences in CD3+ T cells
were observed in the same children during acute versus
recovery phases of malaria. To further delineate the T cell
subsets, the percentage of CD3+ CD4+ and CD3+CD8+
cells in the same samples was analyzed. While no signifi-
cant differences were observed in the percentages of CD4+
and CD8+ cells between children with acute malaria and
following recovery, significantly fewer CD3+ CD4+ cells (P
= 0.04) and more CD3+CD8+ T cells (P = 0.03) were meas-
ured in healthy age-matched controls relative to the chil-
dren that had recovered from acute malaria.
Alterations in memory and naive B cell subsets in children 
with acute clinical malaria
Four major populations of B cells in the peripheral blood
can be distinguished based on expression of IgD and
CD38 [15]: naive 1 (CD38-IgD+), naive 2 (CD38+IgD+),
memory 3 (CD38+IgD-) and memory 4 (CD38-IgD-). To
determine the frequencies of these B cell subsets in the
study population, PBMC were live-gated on CD19+ cells
to collect sufficient number of cells for analysis and then
analysed for expression of IgD and CD38. A representative
FCF analysis is shown in Figure 1A and results for all sam-
ples are reported in Table 2. Children with acute clinical
malaria had significantly lower naive 1 (CD38-IgD+) B cell
subsets compared to the same population following
recovery (P = 0.03) and to age-matched healthy controls
(P = 0.00). In contrast, elevation of the memory 3
(CD38+IgD-) B cell subset was observed in the acute clin-
ical malaria compared to the same population following
recovery (P = 0.00) and to age-matched healthy controls
(P = 0.01). Interestingly, the memory 4 (CD38-IgD-) B cell
subset was significantly lower in both acute clinical
malaria and recovery compared to healthy controls (P =
0.01 and P = 0.00 respectively). This mirrors the increase
in the naive 2 (CD38+IgD+) B cell subset during both
acute clinical malaria and recovery compared to healthy
controls (P = 0.04 and P = 0.01 respectively).
Falciparum malaria results in increases in transitional 
CD19+CD10+ B cells in peripheral blood
CD10 was originally thought to be expressed primarily by
germinal center B cells and Burkitt's lymphoma tumor
cells [17]. However, recently CD10 expression has been
associated with immature transitional B cells [18,19]. To
determine whether acute clinical P. falciparum induces
increased expression of CD10, phenotypic analysis of
peripheral blood of children during acute clinical malaria,
following recovery and in asymptomatic children was per-
Table 2: Mean percentage of lymphocyte subsets at presentation with acute non-complicated malaria, 4 weeks post-recovery and in 
healthy age-matched controls
Acute
(A)
Recovery
(R)
Controls
(C)
Significance
Cell type
mean (SEM) 
percent
mean (SEM) 
percent
mean (SEM) 
percent A vs.R A vs.C R vs.C
CD3+CD45+ 56.9 (2.4) 54.3 (2.3) 52.7 (2.7) 0.37 0.27 0.67
CD19+CD45+ 21.4 (2.1) 26.1 (1.7) 23.5 (2.8) 0.02 0.53 0.41
CD4+CD3+ 34.8 (2.6) 36.0 (2.2) 29.4 (1.9) 0.64 0.14 0.04
CD8+CD3+ 16.0 (2.5) 12.8 (1.2) 18.2 (0.8) 0.22 0.62 0.03
Naive 1
CD38-IgD+CD19+
23.7 (2.9) 29.3 (4.2) 38.2 (3.4) 0.03 0.00 0.12
Naive 2
CD38+IgD+CD19+
39.7 (3.8) 44.7 (4.4) 27.2 (4.4) 0.11 0.04 0.01
Memory 3
CD38+IgD-CD19+
22.7 (2.4) 14.4 (1.3) 14.2 (1.1) 0.00 0.01 0.91
Memory 4
CD38-IgD-CD19+
13.5 (1.4) 11.7 (1.3) 22.8 (2.6) 0.11 0.01 0.00
CD10+CD19+ 24.6 (2.5) 29.0 (2.7) 21.2 (1.8) 0.04 0.31 0.04
Sample size (n) was n = 15 for all Acute & Recovery outcomes except CD19+CD10+ (n = 12), and all Memory and Naive outcomes (n = 11). N = 
11 for controls except for CD4 (n = 10), CD19+CD10+ (n = 9), CD19+CD27+ (n = 7), and CD8 (n = 5). Heterogeneity of variance assumptions 
were tested by the Levene statistic, and heterogeneous t-tests were utilized as needed. Significant differences are in bold.
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formed. The results illustrate that following recovery from
malaria, children had significantly higher levels of CD10
expression than during acute clinical malaria (P = 0.04)
and also compared to controls (P = .04) (Table 2). Impor-
tantly, it was confirmed that the peripheral B cells express-
ing CD10 were negative for CD34 or CD27.
Acute clinical malaria results in 
hypergammaglobulinaemia
Previous studies have demonstrated that acute clinical
malaria is associated with hypergammaglobulinaemia
[8]. To determine if this was also true for these study par-
ticipants, quantitative total immunoglobins (Ig) were
measured using ELISA in the plasma obtained from
PBMC. As shown in Figure 2, increased levels of total Ig
were evident during acute clinical malaria, with children
having significantly higher Ig levels during acute clinical
malaria as compared to post recovery (p < 0.005) and the
controls (p < 0.001). Additionally the Ig levels were signif-
icantly higher post recovery as compared to controls (p <
0.05).
Discussion
Although extensive information is available on the types
and frequencies of mature B cells that populate the
peripheral blood, few studies have been done analysing
how B-cell lymphopoiesis is altered in children infected
Alterations in peripheral B cell subsets in children with acute malaria compared to the same children following recoveryFigure 1
Alterations in peripheral B cell subsets in children with acute malaria compared to the same children following 
recovery. Representative FCF analysis of CD19+ B cells stained for CD38 and IgD. Expression of CD38 and IgD can be used 
to identify naive and memory B cell subpopulations in the peripheral blood [15].
Comparison of serum Ig levels in children with acute malaria, following rec very and ag -matched controlsFigure 2
Comparison of serum Ig levels in children with acute 
malaria, following recovery and age-matched con-
trols. Total human Ig (IgG, IgM and IgA) in plasma was deter-
mined by ELISA analysis. Shown are mean (SEM) Ig levels 
between children with acute malaria (n = 15), the same chil-
dren following recovery and age matched healthy children (n 
= 6). Significant differences between acute (a), recovery (r), 
and controls (c) as noted.
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with P. falciparum malaria. In this study, a significant
decline in the percentages of CD19+ B cells in the periph-
eral blood of children during an episode of acute clinical
P. falciparum malaria compared to the same children post-
recovery and to healthy age-matched children was
observed. In addition, the children with acute malaria had
an increase in a memory B cell subset and a concomitant
decrease in a naive B cell subset in children as compared
to the same children post-recovery and to healthy age-
matched children. Thus, the data presented here suggests
that P. falciparum infection results in perturbations of the
B cell compartment and is consistent with accumulating
evidence from a number of other studies showing dysreg-
ulation of B cell function following P. falciparum infection
[11,21].
Lymphopaenia has long been recognized as a complica-
tion of acute malaria [22]. Consistent with this, there was
a decline in percentages of CD19+ B cells during acute
malaria in this study. However, there were no significant
differences in CD3+ T cells in this same population.
Although the immunological pathways that orchestrate B
lymphocyte depletion are unknown, P. falciparum malaria
may interfere with B cell lymphopoiesis, induce lym-
phocyte apoptosis as shown following infection of
macaques with P. coatneyi [23], or result in sequestration
of lymphocytes to other tissues or endothelium [22].
Lastly, given the hypergammaglobulinaemia that this
study and others [8] have observed following P. falciparum
infection, the possibility exists that P. falciparum infection,
possibly through direct interactions of P. falciparum anti-
gens with memory B cells, is driving memory B cells
towards plasma cell differentiation and migration of these
cells back to the bone marrow. Consistent with this,
changes in B cell subsets were observed, with significantly
higher memory 3 B cell subset observed in acute clinical
malaria compared to recovery or controls, and a lower
percent of memory 4 B cell subset in children both during
acute and following recovery compared to healthy age-
matched controls. Taken together, these observations
have important implications in the maintenance of
immunologic memory to vaccine antigens in populations
chronically exposed to malaria infections, especially in
children since they are most vulnerable to this parasitic
infection.
Elevated levels of the IgD+CD38+ naive 2 equivalent of
pre-germinal center B cells have been reported in the
peripheral blood children with systemic lupus erythema-
tosus [24], but this B cell subset is rarely observed in
peripheral blood of healthy individuals. This study also
reported elevated levels of these pre-germinal center B
cells in children following recovery from acute clinical
malaria. It is unclear whether this reflects interference of
P. falciparum infection with B cell trafficking and/or differ-
entiation, which could lead to cells exiting secondary lym-
phoid organs at early differentiation stages. A recent
report found that the architecture of the germinal center
was disrupted in a mouse model of malaria [25]. Further-
more, Urban and colleagues also observed disruption of
splenic organization in autopsy studies of adults who died
of P. falciparum malaria [26]. Together, these studies point
towards P. facliparum infection resulting in alterations of
lymphoid architecture, which could result in the changes
in peripheral B cell subsets that were observed in this
study.
An expansion of CD10+CD19+ B cells was observed fol-
lowing recovery from acute clinical P. falciparum malaria,
with up to 25% of total CD19+ B cell pool residing in this
subset. The cells expressing CD10 cells were IgD+ and
CD34-, suggesting that they were not pre-B cells that had
aberrantly migrated to the periphery from the bone mar-
row [27,28]. Studies in autoimmune and immunodefi-
ciency diseases have associated the expression of CD10
with immature transitional B cells and their elevated lev-
els in peripheral circulation are thought to be indicative of
B cell dysfunction [18]. Interestingly, Burkitt lymphoma
express CD10 and it this has led to the idea that these
tumors may be derived from CD10+ germinal center B
cells [17]. It is possible that P. falciparum infection induces
immature B cells to leave the bone marrow at an earlier
differentiation stage [15,19], and thereby increase prolif-
eration of B cell subsets that are precursors of eBL. This
may explain the increased risk for Burkitt's lymphoma in
children living in malaria holoendemic regions.
The methods for determining the percentage of lym-
phocyte subsets in peripheral blood have over time,
switched from PBMC isolation and then phenotyping to
direct phenotyping from whole blood. The phenotype of
peripheral blood lymphocytes was analysed following
isolation of PBMC because of the difficulties in timing
when samples were collected, the desire to do a batch
analysis on all the samples to ensure consistency in our
analysis, and the inherent challenges of the clinical setting
in Kenya in which we were working. There are very few
published studies of lymphocyte subsets in healthy chil-
dren and most are based on children living in developed
countries. The present study observed that the mean
CD19+ B cells as a percentage of CD45+ lymphocytes was
23.53% in healthy controls. This is within the range
reported in healthy children and HIV infected children
and is much higher than observed in healthy adults where
the range is typically 12% of total lymphocytes [14]. The
present study also reported higher levels of CD10+CD19+
B cells than reported for one other study examining
CD10+ levels in HIV infected children [14].
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Conclusion
In summary, these results demonstrate that during acute
uncomplicated episodes of P. falciparum malaria in chil-
dren, there were major perturbations in B cell subsets
including a decline in memory B cells and an increase in
transitional CD10+ cells. Understanding the mechanisms
underlying the alterations in B cell lymphopoeisis are
needed to aid in vaccine development.
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